Fig. 5: Baseline and longitudinal analyses of mutational signatures.
A Number of SNVs and mutational signatures detected from tumor tissue WGS; B Emergence of FOLFOX treatment associated mutational signature in blood based WGS in patient #29.
Fig. 5: Baseline and longitudinal analyses of mutational signatures. | npj Precision Oncology
